Harmonizing Global Biospecimen Consent Practices to Advance Translational Research: A Call to Action.
Clin Pharmacol Ther 2016;
101:317-319. [PMID:
27558027 DOI:
10.1002/cpt.461]
[Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2016] [Revised: 07/27/2016] [Accepted: 08/22/2016] [Indexed: 01/14/2023]
Abstract
One of the many challenges of translational medicine is working with research participants to donate biospecimens through an ethical informed consent framework. The increasingly complex ethical and regulatory differences across jurisdictions translates into limitations on use and potential value of biological specimens and their associated data in clinical research. We introduce a call to action for more uniform global standards for collection of biological specimen informed consent data to enable greater advancements in medical research.
Collapse